Search Results Search Sort by RelevanceMost Recent Viewpoint Nov 2005 Medical Ethics and Performance-Enhancing Drugs Carlos R. Hamilton, MD A physician's role in controlling the abuse of performance-enhancing drugs includes educating patients about the harms associated with these drugs and encouraging them to adopt safe and appropriate training programs. Virtual Mentor. 2005;7(11):764-766. doi: 10.1001/virtualmentor.2005.7.11.oped1-0511. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Pagination First page « First Previous page ‹ Previous … Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Current page 18
Viewpoint Nov 2005 Medical Ethics and Performance-Enhancing Drugs Carlos R. Hamilton, MD A physician's role in controlling the abuse of performance-enhancing drugs includes educating patients about the harms associated with these drugs and encouraging them to adopt safe and appropriate training programs. Virtual Mentor. 2005;7(11):764-766. doi: 10.1001/virtualmentor.2005.7.11.oped1-0511.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.